New York State Common Retirement Fund Oramed Pharmaceuticals Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.72 - $9.0 $79,622 - $192,636	-21,404 Reduced 98.8%	260 $1,000
Q1 2022 May 05, 2022	SELL	$8.19 - $13.89 $7,215 - $12,237	-881 Reduced 3.91%	21,664 $187,000
Q4 2021 Feb 02, 2022	BUY	$12.98 - $29.75 $59,396 - $136,136	4,576 Added 25.47%	22,545 $322,000
Q3 2021 Nov 02, 2021	SELL	$12.13 - $23.82 $59,813 - $117,456	-4,931 Reduced 21.53%	17,969 $395,000
Q2 2021 Aug 02, 2021	BUY	$8.34 - $14.59 $190,986 - $334,111	22,900 New	22,900 $306,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.